>
>
BOSTON, Aug. 04, 2022 (GLOBE NEWSWIRE) — Yumanity Therapeutics, Inc. (“Yumanity” or the “Company”) (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and
NEW YORK, July 6, 2022 /PRNewswire/ — Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating
NEW ORLEANS–(BUSINESS WIRE)–Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating
NEW YORK, June 7, 2022 /PRNewswire/ — Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal
3 Penny Stocks That Exploded During Trading Today If you’re looking for the best penny stocks to buy, there are plenty of options to choose
The stock price of Yumanity Therapeutics, Inc. (Nasdaq: YMTX) increased by over 45% during intraday trading today. This is why. The stock price of Yumanity
Yumanity Therapeutics, Inc. to sell its clinical-stage product candidate YTX-7739 as well as its unpartnered discovery-stage neuroscience product candidates and targets to Janssen Pharmaceutica NV
BOSTON, May 12, 2022 (GLOBE NEWSWIRE) — Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for
BOSTON, March 24, 2022 (GLOBE NEWSWIRE) — Yumanity Therapeutics (Nasdaq: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for
